NCT06121050 Can a Patient in Intensive Care be Visited by His or Her Pet?
| NCT ID | NCT06121050 |
| Status | Recruiting |
| Phase | — |
| Sponsor | Centre Hospitalier Universitaire de Saint Etienne |
| Condition | Intensive Care Patients |
| Study Type | INTERVENTIONAL |
| Enrollment | 30 participants |
| Start Date | 2025-07-03 |
| Primary Completion | 2029-03 |
Eligibility & Interventions
Eligibility Fast-Check
Enter your details for a quick preliminary check. This does not replace medical advice.
What to Expect as a Participant
You will actively receive the study intervention — which may be a drug, biologic, device, or procedure.
This trial targets 30 participants in total. It began in 2025-07-03 with a primary completion date of 2029-03.
⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.
Brief Summary
Nearly half of all intensive care patients describe symptoms of anxiety and depression after a stay in the ICU, and one in five has genuine post-traumatic stress disorder. As a result, improving patient experience has become a priority in the ICU, and particular attention is being paid to the need to recreate a familiar environment. Animal-mediated interventions have been developed for a number of patients over many years. These strategies are widely used with elderly patients, and patients with cognitive or psychiatric disorders, for whom the literature shows benefits on anxiety, mood or objective signs of stress. In the vast majority of experiments carried out to date, the animals (mainly dogs) were prepared and educated for contact with patients, and their handlers trained in this activity, rather like guide dogs. Visiting a care facility with a patient's own pet is rarely described. It may run up against obstacles related to the animal's behavior or infectious risks, but it is nevertheless authorized in many establishments.
Eligibility Criteria
Inclusion Criteria: * Conscious adult patients with a pet (dog/cat). * Patients with no or no longer hemodynamic or respiratory failure, or undergoing rehabilitation, after resolution of the acute phase or at the end of life. * Patients affiliated to or entitled under a social security scheme. * Patient who has given written informed consent to participate in the study. Exclusion Criteria: * Non-stabilized acute situation (as assessed by the resuscitator). * Mechanical or amine ventilation or extrarenal purification. * Tracheostomy. * Immunosuppression. * Carriage of multi-resistant bacteria. * Behavioral or consciousness disorders. * Pregnancy. * Skin wounds, extensive burns exceeding 15% of body surface area, external fixator. * Guardianship or trusteeship. * Workload incompatible with the visit * Patient unable to speak French.
Contact & Investigator
Cindy POKRANDT
PRINCIPAL INVESTIGATOR
Centre Hospitalier Universitaire de Saint Etienne
Frequently Asked Questions
Who can join the NCT06121050 clinical trial?
This trial is open to participants of all sexes, aged 18 Years or older, studying Intensive Care Patients. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.
Is NCT06121050 currently recruiting?
Yes, NCT06121050 is actively recruiting participants. Contact the research team at guillaume.thiery@chu-st-etienne.fr for enrollment information.
Where is the NCT06121050 trial being conducted?
This trial is being conducted at Annonay, France, Saint-Etienne, France.
Who is sponsoring the NCT06121050 clinical trial?
NCT06121050 is sponsored by Centre Hospitalier Universitaire de Saint Etienne. The principal investigator is Cindy POKRANDT at Centre Hospitalier Universitaire de Saint Etienne. The trial plans to enroll 30 participants.